1,515
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Identification of downstream targets and signaling pathways of long non-coding RNA NR_002794 in human trophoblast cells

, , , , , , & show all
Pages 6617-6628 | Received 28 Jun 2021, Accepted 26 Aug 2021, Published online: 13 Sep 2021

References

  • Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40(3):213–220.
  • Nirupama R, Divyashree S, Janhavi P, et al. Preeclampsia: pathophysiology and management. J Gynecol Obstet Hum Reprod. 2021;50(2):101975.
  • Ives CW, Sinkey R, Rajapreyar I, et al. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76(14):1690–1702.
  • Rana S, Lemoine E, Granger JP, et al. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094–1112.
  • Jim B, Karumanchi SA. Preeclampsia: pathogenesis, prevention, and long-term complications. Semin Nephrol2017;37( 4):386–397.
  • Lunghi L, Ferretti ME, Medici S, et al. Control of human trophoblast function. ReprodBiol Endocrinol. 2007;5:6.
  • Dhariwal NK, Lynde GC. Update in the management of patients with Preeclampsia. Anesthesiol Clin. 2017;35(1):95–106.
  • Huppertz B. The critical role of abnormal trophoblast development in the etiology of preeclampsia. Curr Pharm Biotechnol. 2018;19(10):771–780.
  • Ridder A, Giorgione V, Khalil A. Preeclampsia: the relationship between uterine artery blood flow and trophoblast function. Int J Mol Sci. 2019;20(13):3263.
  • Azizi Z, Mirtavoos-Mahyari H, Karimi R, et al. Long non-coding RNAs: diverse roles in various disorders. Hum Antibodies. 2019;27(4):221–225.
  • Tsagakis I, Douka K, Birds I. Long non-coding RNAs in development and disease: conservation to mechanisms. J Pathol. 2020;250(5):480–495.
  • Statello L, Guo CJ, Chen LL. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96–118.
  • Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667.
  • Moradi MT, Rahimi Z, Vaisi-Raygani A. New insight into the role of long non-coding RNAs in the pathogenesis of preeclampsia. Hypertens Pregnancy. 2019;38(1):41–51.
  • Yang X, Meng T. Long noncoding RNA in preeclampsia: transcriptional noise or innovative indicators? Biomed Res Int. 2019;2019:5437621.
  • Tang D, Geng L, Ma J. lncRNA PROX1-AS1 mediates the migration and invasion of placental trophoblast cells via the miR-211-5p/caspase-9 axis. Bioengineered. 2021;12(1):4100–4110.
  • Chen Q, Jiang S, Liu H, et al. Association of lncRNA SH3PXD2A-AS1 with preeclampsia and its function in invasion and migration of placental trophoblast cells. Cell Death Dis. 2020;11(7):583.
  • Ma Y, Liang X, Wu H, et al. Long non‑coding RNA NR_002794 is upregulated in pre‑eclampsia and regulates the proliferation, apoptosis and invasion of trophoblast cells. Mol Med Rep. 2019;20(5):4567–4575.
  • Mao M, Zheng X, Jin B, et al. Effects of CD44 and E-cadherin overexpression on the proliferation, adhesion and invasion of ovarian cancer cells. Exp Ther Med. 2017;14(6):5557–5563.
  • Li G, Yang J, Chong T, et al. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway. Anticancer Drugs. 2020;31(6):592–600.
  • Falzone L, Salemi R, Travali S, et al. overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma. Aging (Albany NY). 2016;8(5):933–944.
  • Hou W, Ye C, Chen M, et al. Bergenin activates SIRT1 as a novel therapeutic agent for osteogenesis of bone mesenchymal stem cells. Front Pharmacol. 2019;10:618.
  • Xu Z, Orkwis JA, DeVine BM, et al. Extracellular matrix cues modulate Schwann cell morphology, proliferation, and protein expression. J Tissue Eng Regen Med. 2020;14(2):229–242.
  • Frión-Herrera Y, Gabbia D, Scaffidi M, et al. The cuban propolis component nemorosone inhibits proliferation and metastatic properties of human colorectal cancer cells. Int J Mol Sci. 2020;21(5):1827.
  • Li J, Hu L, Zhou T, et al. Taxifolin inhibits breast cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition viaβ-catenin signaling. Life Sci. 2019;232:116617.
  • Zhang L, Li H, Li M, et al. LRP6 is involved in the proliferation, migration and invasion of trophoblast cells via miR-346. Int J Mol Med. 2020;46(1):211–223.
  • Fangjun L, Zhijia Y. Tumor suppressive roles of eugenol in human lung cancer cells. Thorac Cancer. 2018;9(1):25–29.
  • Gao X, Zhang X, Hu J, et al. Aconitine induces apoptosis in H9c2 cardiac cells via mitochondria-mediated pathway. Mol Med Rep. 2018;17(1):284–292.
  • Liu Y, Shao E, Zhang Z, et al. Derivative induces apoptosis through the mitochondria p53 pathway in HepG2 cells. Front Pharmacol. 2019;10:762.
  • Liu C, Wang H, Yang M, et al. Downregulation of cAMP-dependent protein kinase inhibitor-b promotes preeclampsia by decreasing phosphorylated AKT. Reprod Sci. 2021;28(1):178–185.
  • You X, Cui H, Yu N, et al. Knockdown of DDX46 inhibits trophoblast cell proliferation and migration through the PI3K/Akt/mTOR signaling pathway in preeclampsia. Open life sci. 2020;15(1):400–408.
  • Li M, Cheng W, Luo J, et al. Loss of selenocysteine insertion sequence binding protein 2 suppresses the proliferation, migration/invasion and hormone secretion of human trophoblast cells via the PI3K/Akt and ERK signaling pathway. Placenta. 2017;55:81–89.
  • Xu Y, Sui L, Qiu B, et al. ANXA4 promotes trophoblast invasion via the PI3K/Akt/eNOS pathway in preeclampsia. Am J Physiol Cell Physiol. 2019;316(4):C481–c491.
  • Huang J, Zheng L, Wang F, et al. Mangiferin ameliorates placental oxidative stress and activates PI3K/Akt/mTOR pathway in mouse model of preeclampsia. Arch Pharm Res. 2020;43(2):233–241.
  • Wang Y, Jie L, Gong H, et al. miR-30 inhibits proliferation of trophoblasts in preeclampsia rats partially related to MAPK/ERK pathway. Exp Ther Med. 2020;20(2):1379–1384.
  • Hu H, Jiang J, Chen Q, et al. Cyclophilin A inhibits trophoblast migration and invasion in vitro and vivo through p38/ERK/JNK pathways and causes features of preeclampsia in mice. Life Sci. 2020;261:118351.
  • Li N, Huang L, Li Y, et al. Lin28B/miR-92b promote the proliferation, migration, and invasion in the pathogenesis of preeclampsia via the DKK1/Wnt/β-Catenin pathway. Reprod Sci. 2020;27(3):815–822.
  • Zhang Z, Li H, Zhang L, et al. Differential expression of β-catenin and Dickkopf-1 in the third trimester placentas from normal and preeclamptic pregnancies: a comparative study. ReprodBiol Endocrinol. 2013;11:17.
  • Wang X, Zhang Z, Zeng X. Wnt/β-catenin signaling pathway in severe preeclampsia. J Mol Histol. 2018;49(3):317–327.
  • Schrey-Petersen S, Stepan H. Anti-angiogenesis and preeclampsia in 2016. Curr Hypertens Rep. 2017;19(1):6.
  • Shi M, Chen X, Li H, et al. δ-tocotrienol suppresses the migration and angiogenesis of trophoblasts in preeclampsia and promotes their apoptosis via miR-429/ZEB1 axis. Bioengineered. 2021;12(1):1861–1873.
  • Mueller SB, Kontos CD. Tie1: an orphan receptor provides context for angiopoietin-2/Tie2 signaling. J Clin Investig. 2016;126(9):3188–3191.
  • Yang P, Chen N, Jia JH, et al. Tie-1: a potential target for anti-angiogenesis therapy. J Huazhong Univ Sci Tech Med sci. 2015;35(5):615–622.
  • Seval Y, Sati L, Celik-Ozenci C, et al. The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta. Placenta. 2008;29(9):809–815.
  • Kayisli UA, Cayli S, Seval Y, et al. Spatial and temporal distribution of Tie-1 and Tie-2 during very early development of the human placenta. Placenta. 2006;27(6–7):648–659.
  • Vuorela P, Matikainen MT, Kuusela P, et al. Endothelial tie receptor antigen in maternal and cord blood of healthy and preeclamptic subjects. Obstet Gynecol. 1998;92(2):179–183.